Dermapharm Holding

DMP.DE Mid Cap

Healthcare · Drug Manufacturers - Specialty & Generic

Updated: Apr 5, 2026, 17:43 UTC

€47.25

+1.72% today

52W: €31.70 – €47.25

52W Low: €31.70 Position: 100% 52W High: €47.25

🔗 Compare Brokers

Key Metrics

P/E Ratio

21.98x

Price-to-Earnings

Forward P/E

16.23x

Forward Price/Earnings

P/S Ratio

2.17x

Price-to-Sales

EV/EBITDA

13.35x

Enterprise Value/EBITDA

Div. Yield

186%

Annual dividend yield

Market Cap

$2.5B

Market Capitalization

Revenue Growth

-5.4%

YoY Revenue Growth

Profit Margin

9.88%

Net profit margin

ROE

18.5%

Return on Equity

Beta

0.87

Market sensitivity

Short Interest

—

% of float sold short

Avg. Volume

31,964

Average daily volume

Valuation Analysis

Signal

Fair

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Buy

4 analysts

Avg. Price Target

€43.50

-7.94% upside

Target Range

€34.00 – €48.00

About the Company

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally. The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. I

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic Country: Germany Employees: 3,610 Exchange: GER